2015-05-15T10:16:09-05:00 2014-06-30 Grant Thornton LLP 2010 CORPORATE RIDGE SUITE 400 MCLEAN VA 22102 990 2013-07-01 521654453 CHILDREN'S RESEARCH INSTITUTE % CORPORATE OFFICERS CHIL 3015658484 111 Michigan Avenue NW Suite Washington DC 20010 DOUGLAS MYERS cfo 3015658484 2015-05-15 true mary torretta P00847851 3015658484 2013 2016-02-25 16:41:14Z KURT DOUGLAS NEWMAN MD 111 Michigan Avenue NW Washington DC 20010 63622657 false X www.childrensnational.org/research X 1989 DC CONDUCTS AND PROMOTES TRANSLATIONAL AND CLINICAL MEDICAL RESEARCH AND EDUCATION PROGRAMS. SEE SCHEDULE O. 17 15 0 178 0 47998831 63622657 0 0 0 0 0 0 47998831 63622657 0 0 0 0 37892204 43875658 0 0 0 37732311 43686010 75624515 87561668 -27625684 -23939011 25898442 33871372 148147765 180059706 -122249323 -146188334 X CHILDREN'S RESEARCH INSTITUTE CONDUCTS AND PROMOTES TRANSLATIONAL AND CLINICAL MEDICAL RESEARCH AND EDUCATION PROGRAMS THAT LEAD TO IMPROVED UNDERSTANDING, PREVENTION, TREATMENT, AND CARE OF CHILDHOOD DISEASES. false false 17959087 CENTER FOR TRANSLATIONAL SCIENCE - SEE SCHEDULE O. 17919347 CENTER FOR GENETIC MEDICINE RESEARCH - SEE SCHEDULE O. 11530706 CENTER FOR NEUROSCIENCE RESEARCH ("CNR") - SEE SCHEDULE O. 21143465 68552605 true true false false false false false false false false true false false true true true false true false false false false false false false false false false false true false false false false false false false false false false false false false true false false false true 0 0 0 false false false false false false false false false false X 17 15 false false false false true true true true true false false true true true true true true false false false DC X CORPORATE OFFICERS 3015723502 111 MICHIGAN AVENUE NW WASHINGTON DC 20010 SCOTT KOENIG MD PHD BOARD CHAIRMAN 2.0 1.0 X X 0 0 0 FRED T GOLDBERG JR BD VICE CHAR (EXP: 12/31/2013) 2.0 1.0 X X 0 0 0 DAVID SCHLITZ BD VICE CHAR (BEG: 01/01/2014) 2.0 X X 0 0 0 JOEL WOOD BOD SEC-TREAS (EXP: 12/31/13) 2.0 X X 0 0 0 JAY SCHNITZER MD PHD BOD SEC-TREAS (BEG: 01/01/14) 2.0 X 0 0 0 KURT D NEWMAN MD PRESIDENT / CEO (CNMC) 2.0 53.0 X X 0 1511782 432063 MARK BATSHAW MD PHY IN CHIEF / CAO/ BRD MEM 44.0 11.0 X 0 1213279 327794 KEVIN M FICKENSCHER MD PHD BOARD MEMBER 1.0 X 0 0 0 ADA SUE HINSHAW PHD BOARD MEMBER 1.0 X 0 0 0 ALAN LESHNER PHD BOARD MEMBER 1.0 X 0 0 0 MARY ALICE O'MALLEY BOARD MEMBER 1.0 X 0 0 0 JUTTA PARSONS BOARD MEMBER 1.0 X 0 0 0 EVAN JONES BOARD MEMBER 1.0 2.0 X 0 0 0 ELIZABETH A SANGER BOARD MEMBER 1.0 X 0 0 0 ROBERT TAYLOR MD BOARD MEMBER 1.0 X 0 0 0 B THOMAS MANSBACH BOARD MEMBER (BEG: 01/31/2014) 1.0 1.0 X 0 0 0 PETER HAALAND PHD BOARD MEMBER 1.0 X 0 0 0 DOUGLAS MYERS CHIEF FINANCIAL OFFICER 1.0 54.0 X 0 1033864 122994 MENDAL TUCHMAN MD CHIEF RESEARCH OFFICER 49.0 6.0 X 0 611601 110429 ERIC HOFFMAN PHD RES CTR DIRECTOR GENETICS 50.0 5.0 X 0 378137 152806 ZENAIDE QUEZADO MD RES CTR COMM & CLINICAL 50.0 5.0 X 0 374925 23658 NAOMI C LUBAN MD CHIEF OF LAB MEDICINE 50.0 5.0 X 0 398628 99040 LISA GUAY-WOODFORD MD RES CTR DIR COMM & CLINICAL 50.0 5.0 X 0 411761 50215 JOHN VAN DEN ANKER MD PHD CHIEF OF CLINICAL PHARMACOLOGY 50.0 5.0 X 0 340361 52427 0 6274338 1371426 0 false true true WHITING-TURNER CONTRACTING CO PO BOX 17596 BALTIMORE MD 21297 CONSTRUCTION SERVICE 2703487 GEORGE WASHINGTON UNIVERSITY 2300 EYE STREET NW WASHINGTON DC 20037 RESEARCH SERVICES 1924896 HURON CONSULTING GROUP 4795 PAYSPHERE CIRCLE CHICAGO IL 60674 RESEARCH SERVICES 1065648 SAREPTA THERAPEUTICS INC 215 FIRST STREET STE 7 CAMBRIDGE MA 02142 RESEARCH SERVICES 728081 LIFE TECHNOLOGIES CORP 5791 VAN ALLEN WAY CARLSBAD CA 92008 RESEARCH SERVICES 724510 42 14257641 42589604 6775412 63622657 0 0 0 0 0 0 0 0 0 0 0 0 63622657 0 0 0 0 0 0 38874555 37902691 971864 836862 815940 20922 2017856 1967410 50446 2146385 2092725 53660 0 658809 642339 16470 61 60 1 0 0 0 10352101 10093298 258803 19617 19127 490 1005998 980848 25150 897050 874624 22426 0 353625 344784 8841 676919 659996 16923 0 263615 257025 6590 0 0 313435 305599 7836 78252 76296 1956 OVERHEAD 19998770 2678779 17319991 MEDICAL SUPPLIES 6358497 6199535 158962 CAPITAL EQUIPMENT 272874 266052 6822 SMALL MEDICAL EQUIPMENT 183351 178767 4584 2253036 2196710 56326 87561668 68552605 19009063 0 0 0 100000 0 14281540 18547107 0 0 0 0 0 0 0 0 0 0 0 0 3655298 335078 737632 3320220 0 0 0 0 0 0 0 0 10779270 12004045 25898442 33871372 4586518 4304043 0 0 7939348 7008367 0 0 0 0 0 0 0 0 0 0 135621899 168747296 148147765 180059706 X -122249323 -146188334 0 0 0 0 -122249323 -146188334 25898442 33871372 -23939011 X false true X true true true X 45771511 48636497 53310038 47998831 63622657 259339534 0 0 45771511 48636497 53310038 47998831 63622657 259339534 0 259339534 0 0 0 0 40180 0 0 40180 259379714 0 0.99984 0.99961 X 0.00000 RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 102137 9930 92207 455607 31536 424071 3097554 293612 2803942 3320220 CONSTRUCTION IN PROGRESS 12004045 12004045 0 DUE TO AFFILIATES 168747296 168747296 X Liability for Uncertain Tax Position (ASC 740) Schedule D, Part X, Line 2 FIN 48 FINANCIAL STATEMENT FOOTNOTE FROM THE COMBINED FINANCIAL STATEMENTS OF CHILDREN'S NATIONAL MEDICAL CENTER (MEDICAL CENTER) AND SUBSIDIARIES, OF WHICH CHILDREN'S RESEARCH INSTITUTE IS A SUBSIDIARY, IS AS FOLLOWS: THE MEDICAL CENTER IS A NOT-FOR-PROFIT CORPORATION AS DESCRIBED IN SECTION 501(C)(3) OF THE INTERNAL REVENUE CODE AND IS EXEMPT FROM FEDERAL INCOME TAXES ON RELATED INCOME PURSUANT TO SECTION 501(A) OF THE CODE. ON SUCH BASIS, THE EXEMPT ENTITIES WILL NOT INCUR ANY LIABILITY FOR FEDERAL INCOME TAXES, EXCEPT FOR POSSIBLE UNRELATED BUSINESS INCOME. THE MEDICAL CENTER EVALUATES UNCERTAIN TAX POSITIONS USING A TWO-STEP APPROACH FOR RECOGNIZING AND MEASURING TAX BENEFITS TAKEN OR EXPECTED TO BE TAKEN IN AN UNRELATED BUSINESS ACTIVITY TAX RETURN AND DISCLOSURES REGARDING UNCERTAINTIES IN TAX POSITIONS. THE MEDICAL CENTER HAD NO UNCERTAIN TAX POSITIONS DURING THE YEARS ENDED JUNE 30, 2014 AND 2013. false true false false false false false false false KURT D NEWMAN MD PRESIDENT / CEO (CNMC) 0 778236 0 708157 0 25389 0 343885 0 88178 0 1943845 0 0 MARK BATSHAW MD PHY IN CHIEF / CAO/ BRD MEM 0 602517 0 569896 0 40866 0 262750 0 65044 0 1541073 0 0 DOUGLAS MYERS CHIEF FINANCIAL OFFICER 0 563087 0 395438 0 75339 0 92251 0 30743 0 1156858 0 0 MENDAL TUCHMAN MD CHIEF RESEARCH OFFICER 0 322297 0 260903 0 28401 0 64889 0 45540 0 722030 0 0 ERIC HOFFMAN PHD RES CTR DIRECTOR GENETICS 0 306356 0 69359 0 2422 0 114179 0 38627 0 530943 0 0 ZENAIDE QUEZADO MD RES CTR COMM & CLINICAL 0 361313 0 12094 0 1518 0 12750 0 10908 0 398583 0 0 NAOMI C LUBAN MD CHIEF OF LAB MEDICINE 0 299829 0 74227 0 24572 0 46798 0 52242 0 497668 0 0 LISA GUAY-WOODFORD MD RES CTR DIR COMM & CLINICAL 0 343367 0 67541 0 853 0 28377 0 21838 0 461976 0 0 JOHN VAN DEN ANKER MD PHD CHIEF OF CLINICAL PHARMACOLOGY 0 283453 0 54070 0 2838 0 27554 0 24873 0 392788 0 0 Related Organization Schedule J, Part I, Line 3 CHILDREN'S RESEARCH INSTITUTE ("CRI") RELIES ON ITS PARENT, CHILDREN'S NATIONAL MEDICAL CENTER, TO DETERMINE COMPENSATION FOR CRI'S LEADERSHIP. CHILDREN'S NATIONAL MEDICAL CENTER USED A COMPENSATION COMMITTEE, WRITTEN EMPLOYMENT CONTRACT, INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE. Supplemental nonqualified retirement plan Schedule J, Part I, Line 4b THE FOLLOWING INDIVIDUALS PARTICIPATE IN A NON-QUALIFIED SUPPLEMENTAL RETIREMENT PLAN. THE CONTRIBUTIONS TO THE SUPPLEMENTAL NON-QUALIFIED RETIREMENT PLAN ARE INCLUDED IN SCHEDULE J, PART II, COLUMN (C) AS PART OF DEFERRED COMPENSATION: MARK L. BATSHAW, MD $250,000 KURT D. NEWMAN, MD $331,135 DOUGLAS MYERS $79,501 MENDAL TUCHMAN, MD $52,139 ERIC HOFFMAN, PHD $101,429 NAOMI C. LUBAN, MD $34,048 JOHN VAN DEN ANKER, MD, PHD $14,804 LISA GUAY-WOODFORD, MD $17,500 ORGANIZATION'S MISSION FORM 990, PART I, LINE 1 CHILDREN'S RESEARCH INSTITUTE CONDUCTS AND PROMOTES TRANSLATIONAL AND CLINICAL MEDICAL RESEARCH AND EDUCATION PROGRAMS THAT LEAD TO IMPROVED UNDERSTANDING, PREVENTION, TREATMENT, AND CARE OF CHILDHOOD DISEASES. PROGRAM SERVICE ACTIVITY #1 Form 990, Part III, Line 4A CENTER FOR TRANSLATIONAL SCIENCE: THE CENTER FOR TRANSLATIONAL SCIENCE SUPPORTS THE FULL SPECTRUM OF INVESTIGATORS (FACULTY, TRAINEES, AND STAFF) AT CHILDRENS NATIONAL WHO ARE PERFORMING PATIENT-CENTERED CLINICAL AND TRANSLATIONAL RESEARCH (CTR), AND HEALTH SERVICES RESEARCH (HSR). THE POOL OF SUCH INVESTIGATORS AT CHILDRENS IS LARGE AND GROWING, AND THESE INDIVIDUALS APPROACH THEIR WORK WITH A WIDE RANGE OF EXPERIENCE, EXPERTISE, AND SUPPORT. IT HOUSES BOTH LARGE PROGRAMS OF EXTRAMURALLY FUNDED RESEARCH (E.G. THE CLINICAL AND TRANSLATIONAL SCIENCE AWARD (CTSA) FUNDED BY NIH, THE HRSA-FUNDED PEDIATRIC EMERGENCY CARE AND APPLIED RESEARCH NETWORK/PECARN) AND FACULTY WITH LIMITED FUNDING WORKING ON SPECIFIC, LIMITED PROJECTS. THIS GROWING CENTER EXPENSED $17,959,087 IN FY 2014. PROGRAM SERVICE ACTIVITY #2 Form 990, Part III, LINE 4B CENTER FOR GENETIC MEDICINE RESEARCH: THE CENTER FOR GENETIC MEDICINE RESEARCH RESEARCHES, DIAGNOSES, AND TREATS GENETIC DISORDERS--DISEASES AND CONDITIONS IN CHILDREN THAT ARE CAUSED BY INHERITED GENES THAT DONT FUNCTION NORMALLY. FOUNDED IN 1999, THE CENTER EMPHASIZES TRANSLATIONAL RESEARCH (BENCH-TO-BEDSIDE) AND HARNESSES EMERGING TECHNOLOGIES FOR GENETIC AND PROTEOMIC ANALYSIS. APPROXIMATELY 80 SCIENTISTS STRESS OPEN, COLLABORATIVE, MULTIDISCIPLINARY RESEARCH. RESEARCHERS AT THE CENTER FOR GENETIC MEDICINE RESEARCH CONDUCT BASIC AND CLINICAL RESEARCH INTO SOME OF CHILDHOODS MOST WELL-KNOWN GENETIC DISORDERS, INCLUDING ASTHMA AND LUNG DISEASE, DIABETES, INBORN ERRORS OF METABOLISM, MACULAR DEGENERATION, MUSCULAR DYSTROPHIES, SICKLE CELL DISEASE, OBESITY & METABOLIC SYNDROME AND WHITE MATTER DISEASE. ALMOST ALL OF THE CENTERS PROGRAMS COMBINE BASIC, CLINICAL, AND/OR COMMUNITY RESEARCH, INCLUDING STUDIES OF: MUSCLE PHYSIOLOGY, GENETICS & METABOLISM AND DUCHENNE MUSCULAR DYSTROPHY. THE CENTER FOR GENETIC MEDICINE RESEARCH HAD $17,919,347 IN EXPENSES FY 2014. PROGRAM SERVICE ACTIVITY #3 Form 990, Part VI, Line 4C CENTER FOR NEUROSCIENCE RESEARCH ("CNR"): THE CNR HAS GROWN RAPIDLY IN THE PAST 8 YEARS WITH SIGNIFICANT INCREASES IN THE PROGRAM AND THE GENERATION OF IMPORTANT SCIENTIFIC DISCOVERIES. THE CNR CURRENTLY COMPRISES 39 FACULTY MEMBERS WITH FULL APPOINTMENTS AT OUR ACADEMIC AFFILIATE, THE GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES (GW). IN RECOGNITION OF THESE ACCOMPLISHMENTS, CNMC CONSTRUCTED A NEW FLOOR OF LABORATORY SPACE IN 2008 TO SERVE AS HOME FOR THE CNR AND TO PROVIDE ADDITIONAL SPACE FOR RECRUITMENTS. THE CNR CURRENTLY RESIDES IN OVER 12,000 SQUARE FEET OF OPEN ARCHITECTURE RESEARCH SPACE. WE BELIEVE THAT THE CNR IS NOW UNIQUELY POISED TO ACCOMPLISH ITS MISSION, AS ITS RESEARCH PROGRAM, RESEARCH LABS AND SUPPORTING INFRASTRUCTURES, IS NOW PHYSICALLY LOCATED ON THE 6TH FLOOR OF THE MAIN BUILDING OF CNMC. THIS ALLOWS CLOSE INTERACTIONS BETWEEN BASIC NEUROSCIENTISTS, TRANSLATIONAL NEUROSCIENTISTS AND CLINICIAN NEUROSCIENTISTS, INCLUDING CHILD NEUROLOGISTS, NEONATOLOGISTS, AND CRITICAL CARE PEDIATRICIANS. THIS UNIQUE AND EXCITING SETTING HAS SUPPORTED AND PROMOTED A LARGE NUMBER OF RESEARCH PROJECTS THAT SPAN BASIC, TRANSLATIONAL AND CLINICAL RESEARCH IN NEURODEVELOPMENTAL DISORDERS. THE CNR INCLUDES EIGHT MAJOR AREAS OF RESEARCH, INCLUDING NEURAL STEM CELLS AND DEVELOPMENTAL NEUROBIOLOGY, BRAIN INJURY AND BRAIN PROTECTION, PERINATAL HYPOXIA AND HYPEROXIA, EPILEPSY, NEURO-ONCOLOGY, NEUROFIBROMATOSIS, ATTENTION DEFICIT HYPERACTIVITY DISORDER, AND AUTISM. THE CNR COMPRISES AN EXPANDING GROUP OF HIGHLY PRODUCTIVE LAB-BASED DEVELOPMENTAL NEUROSCIENTISTS, ALL OF WHOM HAVE ESTABLISHED STRONG RESEARCH PROGRAMS AND COLLABORATIONS IN THE AREA OF NEURODEVELOPMENTAL DISORDERS. WHILE THESE INVESTIGATORS HAVE DISTINCT EXPERTISE AND RESEARCH PROGRAMS, THEIR RESEARCH AS A WHOLE IS FOCUSED ON CHILDHOOD NEUROLOGICAL DISORDERS, FROM EARLY STAGES OF WHEN THE NERVOUS SYSTEM IS FIRST ESTABLISHED, TO POSTNATAL STAGES THAT INCLUDE THE FORMATION OF NEURONAL CONNECTIONS AND THE WRAPPING OF NEURONAL PROCESSES BY THE MYELIN INSULATOR. THUS, INVESTIGATORS AT THE CNR HAVE A COMMON GOAL FOR WHICH THEY ARE ALL STRIVING. THE CENTER FOR NEUROSCIENCE RESEARCH HAD $11,530,706 IN EXPENSES FY 2014. OTHER PROGRAM SERVICES Form 990, Part III, LINE 4D CENTRER FOR CANCER AND IMMUNOLOGY RESEARCH: The Center for Cancer & Immunology Research was reorganized to integrate the clinical and research enterprises in oncology, infectious diseases, and hematology, in order to promote and facilitate the conduct of translational research. This reorganization resulted in the establishment of 4 sections: 1. Childhood Cancer 2. Infectious Diseases 3. Cancer Immunology 4. Hematology & Transfusion Medicine In the future sections may be added (Rheumatology, Allergy) or combined (Childhood Cancer and Cancer Immunology), but at this point in time, the creation of these sections provides individual investigators to seek for common research themes as well as better identify their clinical counterparts. Also, the new structure has allowed the CCRI leadership to better develop a strategic goal for the future, including strategic expansion of research programs rather than opportunistic recruitments. While the breadth and depth of the CCRI and Center for Cancer and Blood Disorders allow for the establishment of multiple Institutes (Sickle Cell Disease, Transfusion Medicine, HIV, cancer), the focus for the next 5 years will be the establishment of a comprehensive cancer center that is positioned to apply for NCI designation in 2016-2020, and the establishment of an Institute of Transfusion Medicine (details still being worked on). The Center for Cancer and Immunology Research had $11,116,915 in expenses FY 2014. SHEIKH ZAYED INSTITUTE FOR PEDIATRIC SURGICAL INNOVATION: Launched in September 2009, the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children's National redefines what is possible in surgery for children by combining research and clinical expertise into one collaborative team. The institute develops knowledge, tools, and procedures that benefit children in the Washington DC region, across the country, and around the world. The primary focus is to learn from today's surgeries, and conduct innovative research based on that knowledge to improve pediatric surgery for children. Though the research space officially opened in April 2011, all four initiatives (Pain Medicine; Systems Biology and Personal Medicine; Bioengineering; and Immunology) had significant research projects underway prior to moving into the institute's official home. By the end of FY 11, the Institute had collectively published more than 25 studies in peer reviewed journals across a variety of scientific areas. The Sheikh Zayed Institute for Pediatric Surgical Innovation had $10,026,550 in expenses FY 2014. ORGANIZATION MEMBERS Form 990, Part VI, Line 6, 7A AND 7B CHILDREN'S NATIONAL MEDICAL CENTER IS THE SOLE MEMBER OF CHILDREN'S RESEARCH INSTITUTE AND HAS THE RIGHT TO ELECT DIRECTORS OF CHILDREN'S RESEARCH INSTITUTE. THE ARTICLES AND BY-LAWS OF CHILDREN'S RESEARCH INSTITUTE DESCRIBE CERTAIN RIGHTS RESERVED TO THE SOLE MEMBER. INSTITUTE DESCRIBE CERTAIN RIGHTS RESERVED TO THE SOLE MEMBER. FORM 990 REVIEW Form 990, Part VI, Line 11b THE RELEVANT COMMITTEES OF THE ORGANIZATION AND ITS PARENT ORGANIZATION, CHILDREN'S NATIONAL MEDICAL CENTER, REVIEW APPLICABLE PORTIONS OF THE 990. THE LEGAL AFFAIRS AND AUDIT COMMITTEE REVIEW THE FINANCIAL DISCLOSURES, The legal affairs and audit committee reviews the financial disclosures, the CNAPPI board reviews the public benefit sections, and the executive compensation committee reviews the compensation disclosures. The full board reviewed the entire Form 990. The completed Form 990 is made available to the board of Children's National Medical Center before filing. CONFLICT OF INTEREST POLICY Form 990, Part VI, Line 12c CHILDREN'S RESEARCH INSTITUTE ("CRI") REQUIRES THAT EACH OFFICER, DIRECTOR, AND KEY EMPLOYEE COMPLETE A CONFLICT OF INTEREST FORM AT LEAST EVERY YEAR. IN ADDITION EACH OFFICER, DIRECTOR, AND KEY EMPLOYEE IS INSTRUCTED AND REQUIRED TO AMEND THE CONFLICT OF INTEREST FORM IMMEDIATELY UPON A CHANGE IN STATUS OF ANY OF THE QUESTIONS ON THE FORM. THESE FORMS ARE REVIEWED ANNUALLY BY THE CHIEF LEGAL OFFICER AND CONFLICTS AND INTERESTS ARE NOTED. THE CHILDREN'S RESEARCH INSTITUTE BOARD MAKES A DETERMINATION, BASED ON THE RECOMMENDATION OF THE CHIEF LEGAL OFFICER AS TO WHICH PERSONS SHOULD BE CONSIDERED "INTERESTED PARTIES" BASED ON THE CRITERIA SET FORTH IN THE BOARD'S GOVERNANCE POLICY. CRI FORMALLY ADOPTED THE CONFLICT OF INTEREST POLICY OF ITS PARENT, CHILDREN'S NATIONAL MEDICAL CENTER, DURING ITS MAY-JUNE 2011 BOARD MEETINGS. GOVERNING POLICIES Form 990, Part VI, Lines 13 AND 14 Children's Research Institute ("CRI") is governed by the policies of its parent, Children's National Medical Center ("CNMC"). These policies include a written whistleblower policy and a written document retention and destruction policy. PROCESS FOR DETERMINING COMPENSATION Form 990, Part VI, Line 15a and 15b CHILDREN'S RESEARCH INSTITUTE ("CRI") RELIES ON ITS PARENT, CHILDREN'S NATIONAL MEDICAL CENTER, TO DETERMINE COMPENSATION FOR CRI'S LEADERSHIP. CHILDREN'S NATIONAL MEDICAL CENTER USED A COMPENSATION COMMITTEE, WRITTEN EMPLOYMENT CONTRACT, INDEPENDENT COMPENSATION CONSULTANT, COMPENSATION SURVEY OR STUDY, AND APPROVAL BY THE BOARD OR COMPENSATION COMMITTEE. DOCUMENTS MADE AVAILABLE TO THE PUBLIC Form 990, Part VI, Line 19 CHILDREN'S RESEARCH INSTITUTE MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST. FORM 990 PART IX LINE 11G DESCRIPTION:PROFESSIONAL FEES CONSULTANTS TOTAL FEES:2006919 FORM 990 PART IX LINE 11G DESCRIPTION:SUBCONTRACTS TOTAL FEES:6706821 FORM 990 PART IX LINE 11G DESCRIPTION:PURCHASED MEDICAL SERVICES TOTAL FEES:486586 FORM 990 PART IX LINE 11G DESCRIPTION:PURCHASED PERSONNEL TOTAL FEES:414014 FORM 990 PART IX LINE 11G DESCRIPTION:OTHER PURCHASED RESEARCH SERVI TOTAL FEES:737761 CHILDREN'S HOSPITAL FOUNDATION 111 MICHIGAN AVENUE NW WASHINGTON DC 20010 521640402 FUNDRAISING DC 501(C)(3) 07 CNMC false CHILDREN'S NATIONAL MEDICAL CENTER 111 MICHIGAN AVENUE NW WASHINGTON DC 20010 521640403 HEALTH CARE DC 501(C)(3) 11B, II NA false SAFE KIDS WORLDWIDE 1301 PENNSYLVANIA AVENUE NW WASHINGTON DC 20004 521627574 INJURY PRVNTN DC 501(C)(3) 11A, I CNMC false CHILDREN'S HOSPITAL SELF-INSURANCE TRUST 111 MICHIGAN AVENUE NW WASHINGTON DC 20010 521640399 INSURANCE DC 501(C)(3) 11C, III FI CH false CHILDREN'S HOSPITAL 111 MICHIGAN AVENUE NW WASHINGTON DC 20010 530196580 HEALTH CARE DC 501(C)(3) 03 CNMC false BRAINY CAMPS ASSOCIATION 111 MICHIGAN AVENUE NW WASHINGTON DC 20010 271547370 CHILD CAMPS DC 501(C)(3) 11A, I CH false CHILDREN'S NAT'L ADVOC & PUBLIC POLICY 111 MICHIGAN AVENUE NW WASHINGTON DC 20010 271564354 ADVOCACY DC 501(C)(3) 11B, II CNMC false CHILDREN'S PEDIATRICIANS ASSOC 111 MICHIGAN AVENUE NW WASHINGTON DC 20010 HEALTH CARE DC CNMC NONE false 0 false CHILDREN'S NATIONAL HEALTH NETWORK 111 MICHIGAN AVENUE NW WASHINGTON DC 20010 521996521 HEALTH CARE DC CNMC C Corp false SAFE KIDS WORLDWIDE LTD PO BOX 916 ROAD TOWN TORTOLA VQ INJURY PREVEN VQ CNMC C Corp false BEARACUDA RE PO BOX 69 KY1-1102 GRANDCAYMAN CJ REINSURANCE CJ CNMC C Corp false BEAR CUB REINSURANCE LTD PO BOX 69 KY1-1102 GRANDCAYMAN CJ REINSURANCE CJ CNMC C Corp false false false true false false false false false false false false true true true true false false true